Cancer Advances
  • Home
  • About
  • Our Science
    • Recent Publications
    • Our Target
    • Our Product
  • News & Events
  • Contact
Select Page

April 9, 2021 – Cancer Advances, Inc. Announces Minisymposium Presentation at AACR

Apr 13, 2021 | Press Releases

Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces that its abstract entitled, “Vaccination with Polyclonal Antibody Stimulator (PAS) prevents pancreatic carcinogenesis in the KRAS mouse...

March 18, 2021 – Cancer Advances, Inc. Announces Abstract at AACR

Apr 7, 2021 | Press Releases

Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces that an abstract will be included in the upcoming 2021 American Association of Cancer Research (AACR) Annual Meeting being held virtually...
Next Entries »

Recent Posts

  • Cancer Advances, Inc. Announces Issuance of New U.S. Patent
  • Cancer Advances, Inc. Announces Abstract and Poster Presentation at ASCO GI – Role of an anti-gastrin vaccine (PAS) in combination with a PD-1 antibody on growth and metastasis of gastric cancer
  • Cancer Advances, Inc. Announces Publication, “Gastrin Vaccine Alone and in Combination with an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer” in Frontiers in Oncology
  • Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model
  • Vaccination with Polyclonal Antibody Stimulator PAS Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model

Recent Comments

    © 2020 Cancer Advances, Inc. All rights reserved.